Introduction/Overview Quinine, a naturally occurring alkaloid derived from the bark of the Cinchona tree, represents one of the oldest and most historically significant therapeutic agents in medicine. Its use for the treatment of febrile illnesses was documented in South America long before its active principle was isolated in the early 19th century. For centuries, it … Read more
1. Introduction/Overview Quinine, a naturally occurring alkaloid extracted from the bark of the Cinchona tree, represents one of the oldest and most historically significant therapeutic agents in medicine. Its use for the treatment of febrile illnesses, later identified as malaria, dates back centuries and marked a pivotal advancement in chemotherapeutics. Although its role as a … Read more
Introduction/Overview Primaquine phosphate is an 8-aminoquinoline antimalarial agent of significant historical and contemporary clinical importance. First synthesized in the 1940s, it remains the only drug widely available for the radical cure of Plasmodium vivax and Plasmodium ovale malaria, targeting the dormant hypnozoite stage of these parasites. Its role extends to prophylaxis against all species of … Read more
Introduction/Overview Primaquine phosphate is an 8-aminoquinoline compound that occupies a unique and critical position in the antimalarial pharmacopeia. Unlike most antimalarial agents which target the asexual blood stages of Plasmodium parasites responsible for clinical illness, primaquine’s primary therapeutic value lies in its activity against latent hepatic stages (hypnozoites) of Plasmodium vivax and Plasmodium ovale, and … Read more
Introduction/Overview Ritonavir is a synthetic peptidomimetic agent initially developed as an antiretroviral drug for the management of human immunodeficiency virus (HIV) infection. Its primary clinical significance has evolved from its direct antiviral activity to its pivotal role as a pharmacokinetic enhancer, or booster, for other protease inhibitors and, more recently, for agents in other therapeutic … Read more
Introduction/Overview Ritonavir is a synthetic peptidomimetic agent initially developed as an antiretroviral drug. Its primary clinical significance has evolved from its direct antiviral activity to its pivotal role as a pharmacokinetic enhancer, fundamentally altering the management of HIV infection and other viral diseases. The drug’s potent inhibition of the cytochrome P450 3A4 (CYP3A4) isoenzyme allows … Read more
Introduction/Overview Efavirenz represents a cornerstone non-nucleoside reverse transcriptase inhibitor (NNRTI) in the historical and contemporary management of human immunodeficiency virus type 1 (HIV-1) infection. Its development marked a significant advancement in antiretroviral therapy, contributing to the establishment of highly active antiretroviral therapy (HAART) regimens that transformed HIV from a fatal diagnosis to a manageable chronic … Read more
Introduction/Overview Efavirenz represents a cornerstone non-nucleoside reverse transcriptase inhibitor (NNRTI) in the historical and contemporary management of human immunodeficiency virus type 1 (HIV-1) infection. Its development marked a significant advancement in antiretroviral therapy, contributing to the establishment of highly active antiretroviral therapy (HAART) regimens that transformed HIV from a fatal diagnosis to a manageable chronic … Read more
Introduction/Overview Tenofovir represents a cornerstone nucleoside reverse transcriptase inhibitor (NRTI) in the contemporary management of chronic viral infections, specifically human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its development marked a significant advancement in antiretroviral therapy, offering potent viral suppression with a generally favorable resistance profile. The clinical importance of tenofovir is underscored by … Read more
Introduction/Overview Lamivudine, a synthetic nucleoside analogue, represents a cornerstone agent in the chemotherapeutic management of chronic viral infections. Initially developed and approved for the treatment of human immunodeficiency virus (HIV) infection, its therapeutic utility was subsequently extended to include chronic hepatitis B virus (HBV) infection. The drug’s introduction marked a significant advancement in antiviral therapy, … Read more